1.50
price down icon6.83%   -0.11
after-market 시간 외 거래: 1.52 0.02 +1.33%
loading
전일 마감가:
$1.61
열려 있는:
$1.59
하루 거래량:
173.42K
Relative Volume:
2.31
시가총액:
$218.34M
수익:
-
순이익/손실:
-
주가수익비율:
-6.6756
EPS:
-0.2247
순현금흐름:
-
1주 성능:
-19.35%
1개월 성능:
-16.67%
6개월 성능:
-26.83%
1년 성능:
-45.65%
1일 변동 폭
Value
$1.45
$1.61
1주일 범위
Value
$1.45
$1.88
52주 변동 폭
Value
$1.45
$3.335

Immutep Limited Adr Stock (IMMP) Company Profile

Name
명칭
Immutep Limited Adr
Name
전화
-
Name
주소
-
Name
직원
44
Name
트위터
Name
다음 수익 날짜
2025-02-24
Name
최신 SEC 제출 서류
Name
IMMP's Discussions on Twitter

IMMP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IMMP
Immutep Limited Adr
1.50 218.34M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-17 개시 CapitalOne Overweight
2023-08-03 개시 Robert W. Baird Outperform
2021-08-03 개시 Ladenburg Thalmann Buy
2021-07-16 재개 Maxim Group Buy
2018-09-28 개시 B. Riley FBR Buy
2018-02-15 재확인 Maxim Group Buy
모두보기

Immutep Limited Adr 주식(IMMP)의 최신 뉴스

pulisher
Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025
pulisher
Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025
pulisher
Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times

Dec 17, 2024
pulisher
Dec 12, 2024

Immutep shares new cancer study results - Investing.com

Dec 12, 2024
pulisher
Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times

Oct 17, 2024
pulisher
Sep 17, 2024

Immutep reports positive results in cancer study - Investing.com

Sep 17, 2024
pulisher
Aug 01, 2024

Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia

Aug 01, 2024
pulisher
Jul 22, 2024

Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire

Jul 22, 2024
pulisher
Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024
pulisher
Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Mar 30, 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire

Mar 30, 2023
pulisher
Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Apr 08, 2021

FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology

Apr 08, 2021
pulisher
Dec 30, 2020

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks

Dec 30, 2020
pulisher
Sep 06, 2020

IMMPImmutep Latest Stock News & Market Updates - Stock Titan

Sep 06, 2020
pulisher
Jul 15, 2020

The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance

Jul 15, 2020
pulisher
Jun 01, 2018

Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO - Yahoo Finance

Jun 01, 2018
pulisher
Dec 10, 2017

A Full List of Australia ADRs - Investing.com Australia

Dec 10, 2017
pulisher
Dec 05, 2017

Immutep (IMMP) Stock Price, News & Analysis - MarketBeat

Dec 05, 2017

Immutep Limited Adr (IMMP) 재무 분석

Immutep Limited Adr (IMMP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):